Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

N/ACompletedNCT00920712

Shanghai University of Traditional Chinese Medicine200 enrolled

Overview

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

200

Conditions

Gastritis

Interventions

Weiqi decotionDRUG

Decoction ,two times a day

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of Chronic Atrophic Gastritis * Male of female patients between 18-65 years old * Written informed consent Exclusion Criteria: * Combine with malignant pathology on epithelial dysplasia of gastric mucosa * Combine with duodenal ulcer or gastric ulcer * Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. * Pregnancy or breast feeding women, or unwilling to have contraception.

Locations (1)

Longhua hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

Time frame: 12 weeks

Secondary Outcomes

Indicates of liver and renal function

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.